Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

6.760 -0.070 (-1.02%)
Streaming Delayed Price Updated: 11:28 AM EDT, Apr 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,145
Open 6.830
Bid (Size) 6.500 (100)
Ask (Size) 6.830 (100)
Prev. Close 6.830
Today's Range 6.400 - 6.830
52wk Range 0.2813 - 7.000
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience (HBIO) Earnings Transcript ↗
Harvard Bioscience (HBIO) Earnings Transcript 
Via The Motley Fool
Topics World Trade

Performance

YTD
+937.0%
+937.0%
1 Month
+45.1%
+45.1%
3 Month
+1075.4%
+1075.4%
6 Month
+1581.6%
+1581.6%
1 Year
+1667.3%
+1667.3%

More News

Read More
Harvard Bioscience Inc. (NASDAQ:HBIO) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
Via Chartmill
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Harvard Bioscience Announces Reverse Stock Split
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q3 2025 Results Amid Restructuring Efforts ↗
Via Chartmill
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Specificity (OTCQB: SPTY) Signs LOI with Blackpearl – Global Push to End $250B Ad Tech Fraud – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Fraud
News headline image
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Here are the top movers in Thursday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Harvard Bioscience, Inc. - Common Stock publicly traded?
Yes, Harvard Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Harvard Bioscience, Inc. - Common Stock trade on?
Harvard Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harvard Bioscience, Inc. - Common Stock?
The ticker symbol for Harvard Bioscience, Inc. - Common Stock is HBIO on the Nasdaq Stock Market
What is the current price of Harvard Bioscience, Inc. - Common Stock?
The current price of Harvard Bioscience, Inc. - Common Stock is 6.760
When was Harvard Bioscience, Inc. - Common Stock last traded?
The last trade of Harvard Bioscience, Inc. - Common Stock was at 04/28/26 11:28 AM ET
What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
The market capitalization of Harvard Bioscience, Inc. - Common Stock is 288.57M
How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
Harvard Bioscience, Inc. - Common Stock has 289M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.